nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0973	0.127	CbGbCtD
Ximelagatran—CYP2C9—Glipizide—type 2 diabetes mellitus	0.089	0.116	CbGbCtD
Ximelagatran—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0827	0.108	CbGbCtD
Ximelagatran—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0703	0.0916	CbGbCtD
Ximelagatran—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0703	0.0916	CbGbCtD
Ximelagatran—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0649	0.0845	CbGbCtD
Ximelagatran—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0627	0.0816	CbGbCtD
Ximelagatran—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0573	0.0747	CbGbCtD
Ximelagatran—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0533	0.0694	CbGbCtD
Ximelagatran—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0511	0.0665	CbGbCtD
Ximelagatran—CYP2C9—Glyburide—type 2 diabetes mellitus	0.036	0.0469	CbGbCtD
Ximelagatran—CYP2C9—Losartan—type 2 diabetes mellitus	0.0329	0.0429	CbGbCtD
Ximelagatran—F2—leg—type 2 diabetes mellitus	0.0175	0.284	CbGeAlD
Ximelagatran—F2—hindlimb—type 2 diabetes mellitus	0.0156	0.254	CbGeAlD
Ximelagatran—F2—artery—type 2 diabetes mellitus	0.00958	0.156	CbGeAlD
Ximelagatran—F2—endothelium—type 2 diabetes mellitus	0.00809	0.131	CbGeAlD
Ximelagatran—F2—cardiovascular system—type 2 diabetes mellitus	0.00333	0.0541	CbGeAlD
Ximelagatran—F2—kidney—type 2 diabetes mellitus	0.00326	0.0529	CbGeAlD
Ximelagatran—F2—liver—type 2 diabetes mellitus	0.00206	0.0334	CbGeAlD
Ximelagatran—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.00133	0.0215	CbGeAlD
Ximelagatran—CYP2C9—liver—type 2 diabetes mellitus	0.00082	0.0133	CbGeAlD
Ximelagatran—F2—Hemostasis—MMP1—type 2 diabetes mellitus	8.02e-05	0.00047	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	8.02e-05	0.00047	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GNB3—type 2 diabetes mellitus	8e-05	0.000469	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GIP—type 2 diabetes mellitus	7.89e-05	0.000462	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF2—type 2 diabetes mellitus	7.86e-05	0.000461	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.81e-05	0.000458	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	7.81e-05	0.000458	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CALM1—type 2 diabetes mellitus	7.79e-05	0.000457	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APOA1—type 2 diabetes mellitus	7.67e-05	0.00045	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	7.6e-05	0.000446	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEPR—type 2 diabetes mellitus	7.49e-05	0.000439	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	7.48e-05	0.000438	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	7.46e-05	0.000437	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	7.46e-05	0.000437	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	7.45e-05	0.000437	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	7.45e-05	0.000437	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	7.45e-05	0.000437	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	7.44e-05	0.000436	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	7.41e-05	0.000434	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	7.34e-05	0.00043	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PRKCB—type 2 diabetes mellitus	7.32e-05	0.000429	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	7.32e-05	0.000429	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.3e-05	0.000428	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	7.27e-05	0.000426	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—type 2 diabetes mellitus	7.23e-05	0.000424	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	7.17e-05	0.00042	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.16e-05	0.00042	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TLE4—type 2 diabetes mellitus	6.97e-05	0.000408	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GCG—type 2 diabetes mellitus	6.77e-05	0.000397	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.76e-05	0.000396	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	6.71e-05	0.000393	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	6.66e-05	0.000391	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.64e-05	0.000389	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.48e-05	0.00038	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	6.43e-05	0.000377	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—type 2 diabetes mellitus	6.41e-05	0.000376	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT2—type 2 diabetes mellitus	6.41e-05	0.000376	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.34e-05	0.000372	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP1—type 2 diabetes mellitus	6.31e-05	0.00037	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—AGT—type 2 diabetes mellitus	6.23e-05	0.000365	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—type 2 diabetes mellitus	6.11e-05	0.000358	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.09e-05	0.000357	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—type 2 diabetes mellitus	6.08e-05	0.000356	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.03e-05	0.000354	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	5.98e-05	0.00035	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	5.92e-05	0.000347	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	5.92e-05	0.000347	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	5.84e-05	0.000342	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3R1—type 2 diabetes mellitus	5.82e-05	0.000341	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—type 2 diabetes mellitus	5.82e-05	0.000341	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.77e-05	0.000338	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.77e-05	0.000338	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.76e-05	0.000338	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.76e-05	0.000338	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	5.75e-05	0.000337	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	5.73e-05	0.000336	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	5.68e-05	0.000333	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.65e-05	0.000331	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.65e-05	0.000331	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	5.54e-05	0.000325	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.48e-05	0.000321	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.39e-05	0.000316	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.27e-05	0.000309	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INS—type 2 diabetes mellitus	5.22e-05	0.000306	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.2e-05	0.000305	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.19e-05	0.000304	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.15e-05	0.000302	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—type 2 diabetes mellitus	5.13e-05	0.000301	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.11e-05	0.0003	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INSR—type 2 diabetes mellitus	5.08e-05	0.000298	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—type 2 diabetes mellitus	5.05e-05	0.000296	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.01e-05	0.000294	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.99e-05	0.000293	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.99e-05	0.000292	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.96e-05	0.000291	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.9e-05	0.000287	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	4.84e-05	0.000284	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	4.84e-05	0.000284	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—C3—type 2 diabetes mellitus	4.79e-05	0.000281	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.75e-05	0.000279	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.63e-05	0.000271	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.61e-05	0.000271	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.61e-05	0.000271	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.6e-05	0.00027	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	4.59e-05	0.000269	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	4.59e-05	0.000269	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.55e-05	0.000267	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.49e-05	0.000263	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.49e-05	0.000263	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.47e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.47e-05	0.000262	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.46e-05	0.000261	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.39e-05	0.000258	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	4.38e-05	0.000257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.37e-05	0.000256	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.37e-05	0.000256	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.33e-05	0.000254	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.32e-05	0.000253	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—type 2 diabetes mellitus	4.3e-05	0.000252	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.2e-05	0.000246	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—type 2 diabetes mellitus	4.19e-05	0.000246	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.07e-05	0.000239	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.05e-05	0.000238	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	4.04e-05	0.000237	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	4.04e-05	0.000237	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.02e-05	0.000236	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4e-05	0.000235	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GCG—type 2 diabetes mellitus	4e-05	0.000235	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.95e-05	0.000232	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.94e-05	0.000231	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.92e-05	0.00023	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.92e-05	0.00023	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—type 2 diabetes mellitus	3.85e-05	0.000225	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	3.78e-05	0.000222	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.74e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.68e-05	0.000216	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.68e-05	0.000215	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.64e-05	0.000213	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	3.57e-05	0.000209	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	3.57e-05	0.000209	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.48e-05	0.000204	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	3.48e-05	0.000204	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.45e-05	0.000202	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.4e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.4e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.39e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.37e-05	0.000198	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.34e-05	0.000196	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	3.32e-05	0.000195	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	3.32e-05	0.000195	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	3.32e-05	0.000195	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.29e-05	0.000193	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.27e-05	0.000192	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.24e-05	0.00019	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	3.18e-05	0.000187	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	3.18e-05	0.000187	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.14e-05	0.000184	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.07e-05	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	3.06e-05	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	3.06e-05	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	3.01e-05	0.000176	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.01e-05	0.000176	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	2.96e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	2.96e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	2.96e-05	0.000173	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.95e-05	0.000173	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.89e-05	0.00017	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.87e-05	0.000168	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—C3—type 2 diabetes mellitus	2.83e-05	0.000166	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	2.78e-05	0.000163	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.74e-05	0.000161	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.7e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.69e-05	0.000158	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.69e-05	0.000157	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—type 2 diabetes mellitus	2.67e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.67e-05	0.000157	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.64e-05	0.000155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.63e-05	0.000154	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.63e-05	0.000154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	2.6e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.6e-05	0.000153	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.6e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	2.52e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.52e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	2.52e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.52e-05	0.000147	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.48e-05	0.000146	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.42e-05	0.000142	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.41e-05	0.000141	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.35e-05	0.000138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.34e-05	0.000137	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.3e-05	0.000135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.27e-05	0.000133	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INS—type 2 diabetes mellitus	2.25e-05	0.000132	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	2.24e-05	0.000131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.21e-05	0.00013	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.17e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.17e-05	0.000127	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.16e-05	0.000127	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.09e-05	0.000123	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.07e-05	0.000121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	2.05e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	2.05e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	2.01e-05	0.000118	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	2e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	2e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	2e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.99e-05	0.000116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.97e-05	0.000116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.97e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.95e-05	0.000114	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.93e-05	0.000113	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.86e-05	0.000109	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.8e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.79e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.79e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.79e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.76e-05	0.000103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.74e-05	0.000102	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.72e-05	0.000101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.71e-05	0.0001	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.69e-05	9.91e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.67e-05	9.81e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.66e-05	9.75e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.64e-05	9.61e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.62e-05	9.5e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.62e-05	9.5e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.58e-05	9.27e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.58e-05	9.27e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.57e-05	9.22e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-05	9.18e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.55e-05	9.11e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.55e-05	9.11e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.53e-05	9e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.46e-05	8.55e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.42e-05	8.33e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.34e-05	7.85e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.34e-05	7.85e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.33e-05	7.82e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.32e-05	7.71e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.3e-05	7.64e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.28e-05	7.49e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.28e-05	7.49e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.24e-05	7.28e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.22e-05	7.15e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.19e-05	7e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.19e-05	6.98e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.16e-05	6.79e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.14e-05	6.71e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.1e-05	6.44e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.08e-05	6.32e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.04e-05	6.12e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.03e-05	6.01e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.02e-05	5.99e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-05	5.92e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.82e-06	5.76e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.06e-06	5.31e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	8.9e-06	5.22e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	8.73e-06	5.12e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	8.01e-06	4.69e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	7.66e-06	4.49e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.66e-06	4.49e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	7e-06	4.11e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.52e-06	2.06e-05	CbGpPWpGaD
